Market Place
Sourcing Support
Almirall partners with etherna
12 Dec 2023 //
ENDPTS
Belgian RNA biotech, investing in Series B round
25 Aug 2022 //
ENDPTS
eTheRNA Announces Relocation and Expansion of R&D Facility
05 Apr 2022 //
GLOBENEWSWIRE
eTheRNA Mfg Introduces LNP Formulation Development and Production Service
29 Mar 2022 //
CONTRACTPHARMA
eTheRNA Manufacturing Announces New LNP Formulation Development and Production
28 Mar 2022 //
GLOBENEWSWIRE
eTheRNA Immunotherapies on mRNA-Lipid Nanoparticles for Cancer therapy
28 Feb 2022 //
GLOBENEWSWIRE
eTheRNA inks research agreement with Merck KGaA to access mRNA technologies
03 Feb 2022 //
PHARMABIZ
eTheRNA immunotherapies opens office in Hong Kong
03 Aug 2021 //
PRNEWSWIRE
eTheRNA and Ghent University Announce mRNA Delivery Collaboration
13 Jul 2021 //
PRNEWSWIRE
eTheRNA immunotherapies and Quantoom Biosciences Announce Collaboration
29 Jun 2021 //
PR NEWSWIRE
eTheRNA and Quantoom Biosciences Announce a Strategic Collaboration
28 Jun 2021 //
PR NEWSWIRE
eTheRNA, VUB expand collaboration to engineer next-generation mRNA therapeutics
24 Jun 2021 //
BIOSPECTRUMASIA
eTheRNA and VUB expand strategic collaboration for TetraMix®
23 Jun 2021 //
PRNEWSWIRE
eTheRNA strengthens senior management team with appointment of Michael
07 Oct 2020 //
FIRSTWORLDPHARMA
eTheRNA nabs €34M for mRNA vaccines—including COVID-19 candidate
16 Jun 2020 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.